GLUT-discerning ligands provide valuable investigative tools for the pathophysiological roles of these essential transporters and potential therapeutic approaches to combat GLUT-related diseases, including cancer and metabolic disorders. This evidence concerns the gene SLC2A1 and Other metabolic disease.